Prof Dr. Liu Yang | Bioinformatics | Best Researcher Award
Prof Dr. Liu Yang at Department of General Surgery, Jiangsu Cancer Hospital, China
👨🎓 Profile
👨⚕️ Current Position
Prof. Dr. Yang Liu is a Chief Physician and Associate Professor, serving as the Deputy Head of General Surgery at Jiangsu Cancer Hospital and the Head of Colorectal Surgery at Nanjing Medical University.
📜 Summary
Yang Liu is a prominent figure in colorectal surgery, also acting as a Master’s Supervisor and visiting overseas researcher at Thomas Jefferson University’s BluConner Hospital. His work has earned him multiple accolades in cancer research.
🎓 Education
Yang has completed his medical degree and advanced training in colorectal surgery, although specific institutions are not detailed here.
🏥 Professional Experience
With a focus on complex minimally invasive surgeries, he performs over 150 advanced procedures annually and actively participates in various national and provincial medical associations.
🔬 Research Interests
His research primarily explores ncRNA genomics in relation to colorectal cancer progression and metastasis, alongside developing innovative surgical techniques.
💡 Patents
Yang holds several patents, including:
- 2024: Combination of Scutellarein for colorectal cancer treatment.
- 2023: Multi-angle puncture holder.
- 2020: Circ-0000423 for colorectal cancer drug development.
- 2019: Surgical retractor for lower abdominal tumors.
🏆 Awards
He has received notable awards such as:
- 2021: 2nd Prize for New Medical Technology in Jiangsu for epigenetic fusion in colorectal cancer.
- 2019: 2nd Prize for his study on LINC00152 in colorectal cancer.
LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of STAT3
- Authors: Cao, Y., Zou, Z., Wu, X., Hu, J., Yang, L.
Journal: Gene
Year: 2024
Magnetic resonance imaging-based lymph node radiomics for predicting the metastasis of evaluable lymph nodes in rectal cancer
- Authors: Ye, Y.-X., Yang, L., Kang, Z., Du, M., Li, Z.-X.
Journal: World Journal of Gastrointestinal Oncology
Year: 2024
Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
- Authors: Wang, N., Cao, Y., Si, C., Bao, J., Yang, L.
Journal: Cancers
Year: 2022
FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer
- Authors: Li, D., Jiang, S., Zhou, X., Sun, Y., Yang, L.
Journal: Frontiers in Oncology
Year: 2022
Anal preservation on the psychology and quality of life of low rectal cancer
- Authors: Mei, F., Yang, X., Na, L., Yang, L.
Journal: Journal of Surgical Oncology
Year: 2022